Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1975-05-19
1977-12-20
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 260112R, 424 12, A61K 3900, G01N 3316, G21H 502
Patent
active
040642283
ABSTRACT:
Antigens capable of generating antibodies specific to morphine and other 3-oxybenzomorphan compounds are prepared by conjugating 3-oxybenzomorphan derivatives with immunogenic carriers employing a linking site on an aryl group of the 3-oxybenzomorphan other than the hydroxyl substituent, so as to produce antibodies specific for the material.
REFERENCES:
patent: 3709868 (1973-01-01), Spector
patent: 3822245 (1974-07-01), Spector et al.
patent: 3843696 (1974-10-01), Wagner et al.
patent: 3884898 (1975-05-01), Schneider
Kabat, Structural Concepts in Immunology and Immunochemistry, Holt, Rinehart and Winston, Inc., New York, 1968, pp. 9-26.
Spector, Journal of Pharmacology and Experimental Therapeutics, vol. 178, No. 2, Aug., 1971, pp. 253-258.
Harwood, Pharmacology, vol. 11, 1974, pp. 52-57.
Biological Developments, Inc.
Nucker Christine M.
Padgett Benjamin R.
LandOfFree
Antigens and immunoassays for morphine and related 3-oxybenzomor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antigens and immunoassays for morphine and related 3-oxybenzomor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antigens and immunoassays for morphine and related 3-oxybenzomor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-600169